Across TCGA pan-cancer cohorts, CST12P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated CST12P data layer.
The strongest signal is observed in thymoma (THYM), where higher CST12P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CST12P expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.
THYM, DLBC, and READ are the cancer types where CST12P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.